Covered recipient · General Payments record
HANNAH BAILEY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2022–2025
$644.12
- Reported across 32 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $180.94 | 8 |
| Education | $25.31 | 1 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $47.40 | 2 |
| Vanda Pharmaceuticals Inc. | $46.01 | 1 |
| Alkermes, Inc. | $36.21 | 2 |
| Neurocrine BioSciences, Inc. | $31.99 | 2 |
| E.R. Squibb & Sons, L.L.C. | $25.31 | 1 |
| Sage Therapeutics, Inc. | $19.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alkermes, Inc. | $17.76 | 02/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1222440267 | CMS |
| Alkermes, Inc. | $18.45 | 11/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1222440269 | CMS |
| E.R. Squibb & Sons, L.L.C. | $25.31 | 02/26/2025 | Education | Undisputed | 06/30/2026 | 1184398413 | CMS |
| Neurocrine BioSciences, Inc. | $15.59 | 01/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1242914837 | CMS |
| Neurocrine BioSciences, Inc. | $16.40 | 12/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1242910404 | CMS |
| Otsuka America Pharmaceutical, Inc. | $23.10 | 03/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227574383 | CMS |
| Otsuka America Pharmaceutical, Inc. | $24.30 | 11/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227574386 | CMS |
| Sage Therapeutics, LLC | $19.33 | 02/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1211474937 | CMS |
| Vanda Pharmaceuticals Inc. | $46.01 | 09/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233022118 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.